Company: IMCR
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001671927-25-000014
Chunk: 63

Company: Immunocore Holdings plc
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 8
Chunk 63
---
.9 million were reclassified from Accrued expenses and other current liabilities as of December 31, 2024 as they are no longer required to be paid in the twelve months from the balance sheet date following additional information received in the six months ended June 30, 2025. 

5. Interest-bearing loans and borrowings

Interest-bearing loans and borrowings consisted of the following as of June 30, 2025 (in thousands):Fair ValuePrincipal AmountUnamortized Debt Issuance CostsNet Carrying AmountAmountLevelConvertible senior notes$402,500 $(10,440)$392,060 $347,840 Level 2

10

Table of Contents

Interest-bearing loans and borrowings consisted of the following as of December 31, 2024 (in thousands):Fair ValuePrincipal AmountUnamortized Debt Issuance CostsNet Carrying AmountAmountLevelConvertible senior notes$402,500 $(11,487)$391,013 $337,174 Level 2Interest expense consisted of the following (in thousands): Three Months Ended June 30,Six Months Ended June 30,2025202420252024Convertible senior notesCoupon interest$2,515 $2,480 $5,031 $4,107 Amortization of debt issuance costs530 513 1,039 832 Pharmakon loan — 1,284 — 2,577 Total interest expense$3,045 $4,277 $6,070 $7,516 

6. Share-based compensation

The following table shows the total share-based compensation expense recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (in thousands):Three Months Ended June 30,Six Months Ended June 30,2025202420252024Research and development$2,318 $2,172 $4,499 $4,152 Selling, general and administrative $7,715 $7,828 $15,023 $14,812 

11

Table of Contents

Equity Incentive PlanUnder the Company’s Equity Incentive Plan ("EIP"), the Company may grant market value options, share appreciation rights or restricted shares, restricted share units ("RSUs"), performance share units and other share-based awards to the Company’s employees. The Company’s board members and consultants are eligible to receive awards under the Company’s non-employee sub-plan to